Skip to main content

Advertisement

Table 2 The demographic characteristics of the recruited participants from the seven HDSS sites

From: Treatment outcomes in a safety observational study of dihydroartemisinin/piperaquine (Eurartesim®) in the treatment of uncomplicated malaria at public health facilities in four African countries

Variable Main group n (%) Nested cohort n (%) Total n (%)
Age
 6–11 months 327 (3.4) 6 (0.6) 333 (3.1)
 12–59 months 4327 (45.1) 325 (32.4) 4652 (43.9)
 Above 59 months 4935 (51.5) 671 (67.0) 5606 (52.9)
Enrolment
 Eligible 9589 (98.0) 1002 (76.2) 10,591 (95.4)
 Excluded 68 (0.7) 12 (0.9) 80 (0.7)
 Withdrawn 125 (1.3) 301 (22.9) 426 (3.8)
Sex
 Male 4521 (47.2) 489 (48.2) 5004 (47.3)
 Female 5068 (52.8) 518 (51.7) 5586 (52.7)
Country/site
 Burkina faso    3017 (28.5)
 Nouna 1658 (17.3) 102 (10.2) 1760 (16.6)
 Nanoro 1060 (11.1) 197 (19.7) 1257 (11.9)
 Ghana    4563 (43.1)
 Dodowa 729 (7.6) 155 (15.6) 884 (8.4)
 Kintampo 1763 (18.4) 15 (1.5) 1778 (16.8)
 Navrongo 1627 (17.0) 274 (27.4) 1901 (17.9)
 Mozambique    1965 (18.6)
 Manhiça 1876 (19.6) 89 (8.9) 1965 (18.6)
 Tanzania    1046 (9.9)
 Rufiji 876 (9.1) 170 (17.0) 1046 (9.9)